SCHEMBL6000916

SCHEMBL6000916

[CH2]CC(C)OCCCc1ccno1

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.31
CYP19A1 P11511 2/20 0.31
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31
CYP2D6 P10635 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2089072 0.75 CYP1A2 (0.33) CYP1A2CYP19A1CYP2C9CYP2C19CYP2D6
SCHEMBL358647 0.68
SCHEMBL5175178 0.68 CYP1A2 (0.42) CYP1A2CYP19A1CYP2C9CYP2C19CYP2D6
SCHEMBL7802073 0.65 FAAH (0.43)
SCHEMBL11892701 0.65
SCHEMBL356231 0.64
SCHEMBL5324388 0.63
SCHEMBL20379 0.62
SCHEMBL2095543 0.62 HDAC1 (0.40)
SCHEMBL6435989 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed